RecruitingNot ApplicableNCT05359016

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Sponsor

M.D. Anderson Cancer Center

Enrollment

14,600 participants

Start Date

Dec 22, 2020

Study Type

INTERVENTIONAL

Conditions

Cervical Cancer

Summary

The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.

Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 49 Years

Plain Language Summary

Simplified for easier understanding

This trial is evaluating new technologies and approaches — like HPV self-sampling kits and AI-assisted cervical screening — to make cervical cancer prevention more accessible for women in Mozambique. You may be eligible if: you are a woman between 30 and 49 years old, or any age if you are living with HIV; you have a cervix; you live in Maputo or Gaza province; you are not currently pregnant; and you are willing and able to give your informed consent. You may NOT be eligible if: you have had a total hysterectomy (cervix removed); you have a physical or mental condition that prevents participation; or you are pregnant. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHPV testing of women for cervical cancer screening

Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.